Skip to main content
. Author manuscript; available in PMC: 2023 Jun 22.
Published in final edited form as: Am J Prev Med. 2022 May 4;63(3):392–402. doi: 10.1016/j.amepre.2022.03.011

Table 1.

Adults With T2DM in CHCs That Screen for Social Risks (July 2016‒February 2020)

Characteristics All, column % SDH risk screening documentation group, row %
Food insecurity Housing insecurity Transportation insecurity
Documented Documented Documented
Need No need Not documented Need No need Not documented Need No need Not documented
Patients, n 73,484 3,283 6,620 63,581 1,554 7,876 64,054 1,625 6,341 65,518
Female, % 56.3 4.7 8.9 86.4 2.1 11.1 86.8 2.3 8.9 88.8
Race and ethnicity, %
 Hispanic 36.3 3.1 5.5 91.3 1.1 5.7 93.2 1.2 4.9 93.8
 Non-Hispanic Black 20.4 6.6 12.3 81.1 3.7 19.5 76.9 3.4 14.0 82.6
 Non-Hispanic White 31.6 4.9 9.2 85.9 2.4 8.8 88.8 2.6 7.6 89.8
 Non-Hispanic other 7.2 3.7 12.8 83.4 1.6 15.4 83.0 2.4 13.1 84.5
 No data 4.4 4.0 14.7 81.3 2.4 17.6 80.0 1.9 14.1 84.0
Preferred language, %
 English 60.1 5.4 9.5 85.0 2.7 11.2 86.1 2.8 9.3 87.9
 Non-English 39.9 3.0 8.2 88.8 1.2 10.0 88.8 1.3 7.7 91.0
Age at index encounter
 Median (range) 58 (18, 103) 57 (18, 92) 60 (18, 99) 58 (18,103) 57 (18, 98) 61 (18, 99) 58 (18, 103) 57 (18, 92) 60 (18, 98) 58 (18, 103)
 Group, years, %
  18–39 9.0 4.3 7.2 88.6 2.0 8.2 89.8 1.9 6.6 91.5
  40–64 61.7 5.0 8.1 86.9 2.4 9.6 88.0 2.5 7.9 89.6
  ≥65 29.3 3.5 11.4 85.1 1.6 13.8 84.6 1.7 10.8 87.6
Payer at index encounter, %
 Medicaid 36.5 5.3 7.6 87.1 2.6 9.7 87.6 2.9 7.8 89.3
 Medicare 32.7 4.6 10.0 85.4 2.1 12.1 85.9 2.2 9.8 87.9
 Other public 6.1 1.4 4.1 94.5 0.5 5.5 94.0 0.7 4.1 95.2
 Private 14.1 3.4 14.5 82.1 1.7 17.3 81.0 1.4 13.6 85.0
 Uninsured 10.6 4.3 6.3 89.4 1.9 4.2 93.9 1.9 3.9 94.3
Federal poverty level, %
 >200% 8.3 3.0 12.9 84.1 1.5 10.6 87.9 1.3 9.0 89.7
 ≤200% 78.9 4.7 7.9 87.4 2.2 9.8 88.0 2.4 7.6 90.0
 No data 12.8 4.1 13.2 82.7 1.9 16.3 81.8 1.8 14.6 83.6
Visits per year, %
 1–2 16.0 3.0 7.6 89.3 1.4 8.0 90.7 1.3 6.1 92.6
 3–4 30.1 3.6 8.7 87.7 1.7 9.7 88.6 1.8 7.9 90.4
 5–6 30.0 4.7 9.5 85.8 2.3 11.7 86.0 2.3 9.6 88.1
 ≥7 23.9 6.2 9.8 84.0 2.9 12.6 84.4 3.2 10.1 86.7
Years of observation,a %
 (1.2) 95.3 4.5 9.1 86.5 2.1 10.8 87.1 2.2 8.7 89.0
 (2,3.7) 4.7 4.2 7.8 88.0 2.2 8.7 89.2 2.2 6.5 91.4
Statin medication indicatedb 73.5 4.7 8.9 86.4 2.2 10.6 87.2 2.3 8.6 89.1

Note: These data were representative of 178 clinics spanning 13 U.S. states categorized by regions Midwest (Indiana, Minnesota, Ohio, and Wisconsin), Northeast (Massachusetts), South (Georgia, North Carolina, and Texas), and West (Alaska, California, Montana, Oregon, and Washington). SDH risk group was determined during the observation period. Pearson’s chi-square tests were performed comparing characteristics by whether or not the patient had been screened for the specific SDHs need; all tests were statistically significant at the 0.05 p-value level, except as described below: for food insecurity, sex was not significant, for housing insecurity and transportation insecurity, the statin medication indicated was not significant.

a

Study duration was determined at the patient level and defined by their last primary care encounter date and their first primary care encounter date that occurred at least 1 year before their last primary care encounter. Primary care encounters were identified using the combination of the level of service CPT codes and practitioner type (MD, PA, NP, and DO).

b

Statin indication criteria for patients with T2DM who are not pregnant/breastfeeding and who have not been diagnosed with rhabdomyolysis, end-stage renal disease, or renal failure and who are either (1) aged 40−75 years or (2) aged >21 years with atherosclerotic cardiovascular disease or low-density lipoprotein ≥160 mg/dL.

CHC, community health center; CPT, current procedural terminology; DO, doctor of osteopathic medicine; MD, doctor of medicine; NP, nurse practitioner; PA, physician assistant; SDH, social determinant of health; T2DM, type 2 diabetes mellitus.